⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight
globenewswire.com
INCY
ACRS
TAK
AZN
PFE
GSK
JNJ
NVS
SNY
BHC
REGN
ABBV
ALGN
BMY
AMGN
ARCT
CANF
Clinical Trial Supply and Logistics Market Forecast to Reach USD 8.58 Billion by 2034 as Biologics, Global Trials and Cold-Chain Requirements Reshape Supply Networks
globenewswire.com
CAT
AMZN
AMGN
BMY
CRIS
EXPE
FDX
GILD
IQV
LLY
MRK
NVS
PFE
REGN
SNY
TEVA
UPS
VRTX
Global Peptide Drug Conjugate Market Forecast to 2031: Sales, Pricing, Patents, Technologies and Clinical Pipeline | USD 1.5 Billion Opportunity as 50+ Candidates Drive Growth
globenewswire.com
NVS
ONCO
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
globenewswire.com
NVS
MSFT
Global Orphan Drugs Market Size, Share and Trends Analysis Report, 2026-2033 | Market to Reach USD 434.9 Billion as Gene and Cell Therapies Drive 9.0% CAGR
globenewswire.com
JNJ
AZN
NVS
VRTX
SNY
AMGN
MRK
BMY
PFE
The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme
businesswire.com
GILD
BMY
NVS
LLY
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
globenewswire.com
NVS
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
globenewswire.com
NVS
Glioblastoma Multiforme (GBM) Market Size, Epidemiology, Competitive Landscape and Forecast to 2036
globenewswire.com
MRK
NVS
LULU
INCY
REGN
INO